pH/glutathione dual-responsive copper sulfide-coated organic mesoporous silica for synergistic chemo-photothermal therapy

J Colloid Interface Sci. 2024 Mar:657:1-14. doi: 10.1016/j.jcis.2023.11.146. Epub 2023 Nov 25.

Abstract

Nanodrug delivery systems (NDSs), such as mesoporous silica, have been widely studied because of their high specific surface area, high loading rate, and easy modification; however, they are not easily metabolized and excreted by the human body and may be potentially harmful. Hence, we aimed to examine the synergistic anti-tumor effects of ex vivo chemo-photothermal therapy to develop a rational and highly biocompatible treatment protocol for tumors. We constructed a biodegradable NDS using organic mesoporous silica with a tetrasulfide bond structure, copper sulfide core, and folic acid-modified surface (CuS@DMONs-FA-DOX-PEG) to target a tumor site, dissociate, and release the drug. The degradation ability, photothermal conversion ability, hemocompatibility, and in vitro and in vivo anti-tumor effects of the CuS@DMONs-FA-DOX-PEG nanoparticles were evaluated. Our findings revealed that the nanoparticles encapsulated in copper sulfide exhibited significant photothermal activity and optimal photothermal conversion rate. Further, the drug was accurately delivered and released into the target tumor cells, annihilating them. This study demonstrated the successful preparation, safety, and synergistic anti-tumor effects of chemo-photothermal therapeutic nanomaterials.

Keywords: DOX; Degradable materials; Tumor microenvironment; chemo-photothermal therapy; pH/GSH dual-response.

MeSH terms

  • Copper / chemistry
  • Copper / pharmacology
  • Doxorubicin
  • Humans
  • Hydrogen-Ion Concentration
  • Hyperthermia, Induced*
  • Nanoparticles* / chemistry
  • Neoplasms* / drug therapy
  • Neoplasms* / pathology
  • Phototherapy
  • Photothermal Therapy
  • Silicon Dioxide / chemistry
  • Sulfides / pharmacology

Substances

  • Doxorubicin
  • Copper
  • Silicon Dioxide
  • Sulfides